It turns out that 2/3rd of our world's population are still deprived of safe and affordable surgery.
According to a major new Commission, 5 billion people worldwide do not have access to safe and affordable surgery and anaesthesia when they need it, and access is worst in low-income and lower-middle income countries, where as many as 9 out of 10 people cannot access basic surgical care.
Just under a third of all deaths in 2010 (32.9 percent, 16.9 million deaths) were from conditions treatable with surgery - well surpassing the number of deaths from HIV / AIDS, TB, and malaria combined. Yet, despite this enormous burden of death and illness -which is largely borne by the world's poorest people - surgery has, until now, been overlooked as a critical need for the health of the world's population. As a result, untreated surgical conditions have exerted substantial but largely unrecognized negative effects on human health, welfare, and economic development.
Lead author Lars Hagander from Lund University said that the problem for people dying from common, treatable surgical conditions, such as appendicitis, obstructed labour, and fractures, was especially acute in the low- and middle-income countries of eastern, western and central sub-Saharan Africa, and South and Southeast Asia.
Another of the Commission's lead authors, Andy Leather, said that in the absence of surgical care, common, easily treatable illnesses become fatal, and hence, the global community couldn not continue to ignore this problem.
Despite the overwhelming magnitude of the problem, the Commission estimates that the countries where access to surgery is weakest could be scaled up to acceptable, and achievable, levels of access to surgery by 2030 with an investment of US 420 billion dollars, a cost far outweighed by the devastating economic cost to countries, communities, and families incurred by the current global shortfall in access to surgery.
This highly cost-effective investment in surgery needs to be accompanied by sustainable financing mechanisms across the health care system, say the authors, and a firm commitment to universal health coverage.
Professor John Meara, Kletjian, another lead author added that there was a pervasive misconception that the costs of providing safe and accessible surgery put it beyond the reach of any but the richest countries. However, their work clearly showed that not only were the costs of providing these essential services lower than might have been thought, but that scale-up of surgical and anaesthesia care should be viewed as a highly-cost-effective investment, rather than a cost.
The findings are published in the journals Surgery and The Lancet Global Health.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
